To include your compound in the COVID-19 Resource Center, submit it here.

Alnylam, Silence Therapeutics, BASF, Sanofi, Max Planck Society, MIT, University of Massachusetts, Whitehead Institute chemistry news

Alnylam said the Opposition Division of the European Patent Office (EPO) upheld the company's Tuschl I patent, European Patent No. 1309726. The patent includes 14 claims broadly covering the

Read the full 292 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE